The molecular basis of cardiac arrhythmias

Journal of Nuclear Cardiology

Volumn 9, Issue 2, 2002, Pages 206-214

  Shivkumar, Kalyanam ^a   Murali, Narayana S ^b   Krishnan, Subramaniam C ^c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b MAYO CLINIC   (United States)

^c HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACTILE PROTEIN; ION CHANNEL; STRUCTURAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ELECTROCARDIOGRAM; GENE MUTATION; GENETIC ANALYSIS; HEART ARRHYTHMIA; HEART BLOCK; HEART DILATATION; HEART ELECTROPHYSIOLOGY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MOLECULAR BIOLOGY; MUSCLE ACTION POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

EID: 0036521076     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.122763     Document Type: Article

References (30)

1. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HJ, Kleber AG, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999;99:518-28.
2. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HJ, Kleber AG, et al. Genetic and molecular basis of cardiac arrhythmias. impact on clinical management part III. Circulation 1999;99:674-81.
3. Weiss JN. Ion channels in cardiac muscle. In: Langer GA, editor. The mammalian myocardium. 2nd ed. San Diego: Academic Press; 1997. p. 101.
4. Snyders DJ. Structure and function of cardiac potassium channels. Cardiovasc Res 1999;42:377-90.
5. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia. HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
6. Krishnan SC, Shivkumar K, Garan H, Ruskin JN. Increased vulnerability of the subendocardium to ischaemic injury. an electrophysiological explanation. Lancet 1995;346:1612-4.
7. Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT, George M, George M. Cober Lecturer. Mark T. Keating. Molecular basis of the long-QT syndrome associated with deafness. Proc Assoc Am Physicians 1997;109:504-11.
8. Towbin JA, Vatta M. Molecular biology and the prolonged QT syndromes. Am J Med 2001;110:385-98.
9. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995;92:3381-6.
10. Compton SJ, Lux RL, Ramsey MR, Strelich KR, Sanguinetti MC, Green LS, et al. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996;94:1018-22.
11. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999;354:1625-33.
12. Shivkumar K. Images in cardiovascular medicine. Labile repolarization from "cell to bedside." Circulation 2000;102:817-8.
13. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
14. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-600.
15. Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999;34:2035-42.
16. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-90.
17. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200.
18. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 1983;245:C1-14.
19. Lerman BB, Dong B, Stein KM, Markowitz SM, Linden J, Catanzaro DF. Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2. J Clin Invest 1998;101:2862-8.
20. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001; 344:1823-31.
21. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
22. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998;97:2049-58.
23. Schultz KR, Gajarski RJ, Pignatelli R, Goytia V, Roberts R, Bachinski L, et al. Genetic heterogeneity in familial dilated cardiomyopathy. Biochem Mol Med 1995;56:87-93.
24. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993;87:1854-65.
25. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-2.
26. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 1996;97:528-32.
27. Brink AJ, Torrington M. Progressive familial heart block-two types. S Afr Med J 1977;52:53-9.
28. Brink PA, Ferreira A, Moolman JC, Weymar HW, van der Merwe PL, Corfield VA. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 1995;91: 1633-40.
29. Nguyen-Tran VT, Kubalak SW, Minamisawa S, Fiset C, Wollert KC, Brown AB, et al. A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages. Cell 2000;102:671-82.
30. Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler SE, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 1996;123:285-92.